Invivyd, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:IVVD) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -37.61 M-21.13 M-13.3 M-8.25 M-15.46 M-41.71 M -78.72 M Cash from investing activities 5 000-144 K-11 K00-726 K -737 K Cash from financing activities 77 K10 K131 K58.31 M157.18 M-98 K 215.52 M Free cash flow -37.61 M-21.13 M-13.31 M-8.25 M-15.46 M-42.44 M -79.45 M

News

Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates

Upstream Bio, Inc. (UPB) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

Invivyd: Why The Trial Upsizing Isn't The Green Light Bulls Think It Is (NASDAQ:IVVD)

Invivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate - Slideshow (NASDAQ:IVVD) 2026-04-09

Invivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate Transcript

Invivyd, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IVVD) 2026-03-08

Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript

Invivyd Q4 2025 slides: revenue surges 31%, pipeline advances

Invivyd earnings beat by $0.11, revenue topped estimates

Invivyd appoints Michael Mina as chief medical officer

MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates